Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-091-4 | CAS number: 68515-49-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://chesar.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study is rated a "2" because appropriate testing methods were used; however, the study does not follow and accepted guideline or indicate compliance with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
Materials and methods
- Objective of study:
- metabolism
- GLP compliance:
- not specified
Test material
- Reference substance name:
- 1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-rich
- EC Number:
- 271-091-4
- EC Name:
- 1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-rich
- Cas Number:
- 68515-49-1
- Molecular formula:
- C28 H46 O4
- IUPAC Name:
- 1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10 rich
- Reference substance name:
- 1,2-benzenedicarboxylic acid, di-C9,C10 and C11 branched alkyl ester, C10 Rich
- IUPAC Name:
- 1,2-benzenedicarboxylic acid, di-C9,C10 and C11 branched alkyl ester, C10 Rich
- Details on test material:
- Unspecified DIDP; CAS No not provided
Constituent 1
Constituent 2
- Radiolabelling:
- yes
- Remarks:
- 14C-DIDP
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: adult
- Weight at study initiation: 200g
- Housing: individually
- Individual metabolism cages: yes
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 2 days
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: head only
GENERATION OF TEST ATMOSPHERE / CHAMPER DESCRIPTION
As described in Pegg (1979). Toxicity and biologic fate of di-2-ethylhexyl phthalate following inhalation exposure in rats. GM Research Report. RI-135 - Duration and frequency of treatment / exposure:
- The day of the experiment the rats were exposed to 14C DIDP aerosol atmosphere (nominal concentration 100 mg/m3) for 6 hours.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
100 mg/m3
- No. of animals per sex per dose / concentration:
- 6 rats/dose
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- Immdiately following the exposure, three animals were sacrificed and tissues frozen for analysis. The other three animals were transferred directly to th eRoth-type cages and collections begun. Airflow in the cages was maintained at 500 ml/min. Feces was collected for 24 hour intervals at room temperature. Urine receptacles were maintained in dry ice and changed at 12 hour intervals. All samples were stored at -10 deg C for analysis.
Seventy-two hours after the exposure, at termination of the collection period, the animals were sacrificed. Carcasses were skinned and lungs, liver, heart, spleen, kidneys, brain, testes, thymus, and samples of retroperitoneal fat were weighed and frozen. The frozen organ tissues were pulverized and samples taken for analysis. Carcas and feces were homogenized in distilled water. Radioactivity in organ tissues, skin, and feces and carcass homogenates was assayed at 14CO2 evolved from combustion in an RJ Harvey biological materials oxidizer and quanified by liquid scintillation spectromtery. Radioactivity in urine was determined by direct addition of 0.1 ml to 20 ml Aquasol liquid scintillation cocktail. Data were expressed as umole equivalents. DIDP. - Statistics:
- Data were analyzed using the Student's t test and random complete block analysis of variance. Regression and linearity of interval excretion data were tested by analysis of variance. The 0.05 level of probability was used as the criterion of significance.
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Total body burden following the exposure was 6.75 umole equivalents or ~3.0 mg. The excretion of radioactivity was distributed equally between urinary and fecal routes through the 72 hour sampling period, comprising 45.3 and 41.3% respectively of the total body burden. The remaining radioactivity was recovered in carcas (9.4%), skin (2.4%) and in acetone:water (50:50) rinses of the metabolism cage surfaces (1.6%).
- Details on distribution in tissues:
- The distribution of radioactivity in rat tissues immediately following the 6 hour 14C-DIDP inhalation exposure and after 72 hours was measured. The highest concentration of radioactivity was detected in lung immediately after exposure, followed by gastrointestinal tract, liver and kidney. The remaining tissues, brain, thymus, heart, spleen, fat and testes contained far lesser amounts.
After 72 hours the concentration was decreased in all tissues. The highest levels of radioactivity were still found in lung, which contained 27% of the content of 14C present immediately following exposure. The pulmonary content of radioactivity decreased to a lesser extent than all other tissues except fat, which did not appear to change. Radioactivity was below detection limits in brain, spleen, and testes. Heart tissue in only 1 of 3 animals contained detectable quantities of radioactivity.
- Details on excretion:
- The excretion of radioactivity in urine during the 72 hour collection period following inhalation exposure was best described using first order kinetics. Based on 12 hour interval excretion data the hal-life of elimination was 16 hours with an elimination rate constant, Ke, or 0.042 hr-1. Though the analysis was limited with only 3 data points, when tested for regression it was found the points did not represent a straight line.
Using total recovered radioactivity to represent body content or body burden of 14C immediately following exposure, and given urinary and fecal interval excretion data, an estimate of the disappearance of radioactivity from the whole body with time can be obtained. The decline in body burden is linear and apparent first order with a half life of 26 hours and an elimination rate constant, Ke, of 0.027 hr-1.
Applicant's summary and conclusion
- Conclusions:
- The data indicate that inhaled DIDP is metabolized and excreted rapidly exhibiting a low order of toxicity.
- Executive summary:
The fate of DIDP was evaluated in 6 male Sprague Dawley rats (mean body weight 200 g) receiving head only exposure to 14C-DIDP aerosol atmosphere nominal concentration: 100 mg/m3 for 6 hours (General Motors Research Laboratories, 1981). The mass median aerodynamic diameter of DIDP aerosol was 0.98 μm. Three animals were sacrificed immediately following exposure, the remaining animals at the end of the 72-hour collection period. Feces were collected at 24-hour intervals and urine was collected at 12-hour intervals for 72 hours. The radioactivity was determined by liquid scintillation spectrometry.
Absorption: Total body burden following the exposure was 6.75 μmole equivalents or approximately 3 mg. Radioactivity derived from 14C -DIDP was excreted in urine and feces during the 72-hour post-exposure collection period: 45.3% and 41%, respectively, of the total body burden. At the end of the collection period following exposure, 9.4% of the absorbed dose of radioactivity was recovered from carcass and tissues, 2.4% from skin and 1.6% from cage wash.
Distribution: The distribution of radioactivity in rat tissues immediately following exposure, indicated the highest concentration of radioactivity was in lung followed by GIT, liver and kidney. The remaining tissues contained far lesser amounts. Radioactivity was below detection limit in brain, spleen and testes.
Elimination: After 72 hours the concentration was decreased in all tissues. The highest level of radioactivity was still found in lung which contained 27% of the content of radioactivity present immediately following exposure. The pulmonary load decreased to a lesser extent than all the tissues except fat which did not appear to change. Radioactivity derived from 14C -DIDP was excreted in urine and feces during the 72-hour post-exposure collection period: 45.3% and 41%, respectively, of the total body burden. The excretion of radioactivity in urine during the 72-hour collection period following inhalation exposure was best described using first order kinetics. Based on 12-hour interval excretion data, the half-life (T½) of elimination was 16 hours with an elimination rate constant Ke of 0.042/hour. Radioactivity derived from 14C -DIDP was excreted in urine (45.3%) and feces (41.3%) during the 72-hour post-exposure collection period. An additional 1.6% was recovered in washings of the metabolic cage collection surfaces and was derived from urine and fecal contamination. From these data 88% of the total absorbed dose of the radioactivity was excreted from the body, and the carcass retention data imply that a small fraction of DIDP or metabolites was retained in the body for a longer period of time. Using total recovered radioactivity to represent body content or body burden of 14C immediately following exposure, and given urinary and fecal interval excretion data, an estimate of the disappearance of radioactivity from the whole body with time can be obtained. The decline in body burden was linear with an apparent first order with T½ of 26 hours and an elimination rate constant Ke of 0.027/h.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)